Sergio Crispino - Concepedia

Author

Sergio Crispino

Azienda Ospedaliera San Gerardo

Also Known As

Crispino S., S Crispino, S. CRISPINO, S. Crispino, Sergio Crispino

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliera San Gerardo University of Milan University of Siena Centro di Riferimento Oncologico Azienda Ospedaliera Ospedale Civile di Legnano

About

Sergio Crispino is an author at Azienda Ospedaliera San Gerardo specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	24	853
2	Endocrinology	6	6	174
3	Health Sciences	5	5	316
4	Arts	1	1	32
5	Cell Biology	1	1	26

Sergio Crispino

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
ReDO_DB: the repurposing drugs in oncology database Pan Pantziarka, Ciska Verbaanderd, Vidula Sukhatme, ecancermedicalscience Possible Cancer TreatmentsChemoprevention StrategyPharmacotherapyTumor BiologyOncology	2018	130
Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy—a multicenter randomized trial Patrizia Olmi, Sergio Crispino, C. Fallai, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyRadiation TherapyConcomitant RadiotherapyMedicineConventional Radiotherapy	2002	128
Endocrine and immune effects of melatonin therapy in metastatic cancer patients Paolo Lissoni, Sandro Barni, Sergio Crispino, European Journal of Cancer and Clinical Oncology Endocrine-related CancerMedicineImmunologyPharmacologyImmune Effects	1989	95
Art therapy with cancer patients during chemotherapy sessions: An analysis of the patients' perception of helpfulness Silvia Forzoni, Michela Perez, Angelo Martignetti, Palliative & Supportive Care	2010	75
Triple-Negative Breast Cancer: Current State of the Art Francesca Rastelli, Sandra Biancanelli, Amalia Falzetta, Tumori Journal	2010	70
Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cancer patients resistant to interferon-alpha Paolo Lissoni, Sandro Barni, Antonio Ardizzoia, European Journal of Cancer UrologyLow-dose Subcutaneous Interleukin-2Genitourinary CancerMedicineImmunology	1992	57
Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as Pan Pantziarka, Vidula Sukhatme, Sergio Crispino, ecancermedicalscience Molecular PharmacologyPulmonary Arterial HypertensionDrug RepositioningUrologySelective Phosphodiesterase 5	2018	52
The performance of SF-36 health survey in patients with laryngeal cancer Paola Mosconi, Stefania Cifani, Sergio Crispino, Head & Neck	2000	48
Long-Term Results of Conventional Radiotherapy versus Accelerated Hyperfractionated Radiotherapy versus Concomitant Radiotherapy and Chemotherapy in Locoregionally Advanced Carcinoma of the Oropharynx C. Fallai, Andrea Bolner, Marco Andrea Signor, Tumori Journal	2006	45
Increased Level of Soluble Interleukin-2 Receptor in Advanced Solid Tumors: A Preliminary Study Franco Rovelli, Paolo Lissoni, Sergio Crispino, Tumori Journal ImmunologyPathologySoluble Il-2rImmunotherapyAdvanced Solid Tumors	1988	38

Page 1